While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

People with all forms of multiple sclerosis experience disease progression from the beginning of their disease. Therefore, delays in diagnosis and treatment can negatively impact people with multiple ...

Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults ...

Multiple sclerosis (MS) is a progressive autoimmune disease that develops when the immune system attacks the myelin sheath (fatty coating of nerves) of nerves in the brain, spinal cord, and/or eyes.

Respiratory problems can occur in advanced multiple sclerosis (MS). Generally, mild dyspnea (shortness of breath) during strenuous activity is more common in MS than severe respiratory impairment or ...

Multiple sclerosis (MS) causes many symptoms that can disrupt your quality of life. A less commonly known issue is its association with several different sleep problems. Multiple sclerosis (MS) is ...

Ozanimod is an approved treatment for relapsing forms of multiple sclerosis (RMS) that has been shown to reduce relapses, new brain lesions, and brain volume loss relative to intramuscular interferon ...

A chronic and progressive neurological condition that affects millions across the world, multiple sclerosis (MS) can be a complete life-changer. Given how the disease attacks the central nervous ...

The most common side effects seen with Kesimpta are upper respiratory tract infection (an infection in the nose or throat, sore throat, or common cold symptoms), headache, injection-related ...

Maillart E, Redolfi S, Louapre C, et al. Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: a cross-sectional cohort. Mult Scler. 2024;30 (6):726-737. doi:10. ...

Summary Background COVID-19 vaccination is recommended for patients with multiple sclerosis (pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV-2 vaccines in this ...